The EPS projection of InvenSense, Inc. (NYSE:INVN) for quarter ended 2016-09-30 is $-0.05. Last week, the EPS forecast was $-0.05 against target of $-0.05, a month earlier. Two months ago, this estimate was $-0.05 versus forecast of $-0.05 three months earlier, implying a deviation of 0%.
InvenSense, Inc. (NYSE:INVN) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 2.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for InvenSense, Inc. (NYSE:INVN) in the preceding 30, 120, 60 and 90 days were 0, 3, 3, and 3, correspondingly.
InvenSense, Inc. (NYSE:INVN) EPS target for the quarter closed 4 was $-0.05, based on 4 recommendations. As reported on 2016-05-09 the EPS was $-0.08. The change was $-0.01, implying a percentage deviation of -14.29%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
InvenSense, Inc. (NYSE:INVN) yearly sales prediction for the fiscal 2018 stands at $90.94 and the median estimate is at $91. Almost 3 analysts issued sales target.
Highest sales target is $101.32 while the lowest target is $80.5 showing standard deviation of 10.41%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. InvenSense, Inc. (NYSE:INVN) announced that the deviation in forecast was -13.136%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...